Ellipsoid Zone Hyporeflectivity as an Early Sign of Non-Reversible Hydroxychloroquine Retinopathy: A Case Series
Abstract
Introduction: The purpose of this study was to evaluate the progression of hydroxychloroquine (HCQ) retinopathy following parafoveal loss of the ellipsoid zone (EZ) without retinal pigment epithelium damage (RPE).
Methods: This was a single-center retrospective case series of patients with hydroxychloroquine retinopathy who presented between 2012 and 2023 and in whom the drug was stopped prior to damage of the RPE. Patient imaging from the time of HCQ discontinuation to the most recent follow up appointment was reviewed to assess for retinopathy progression, and spectral domain optical coherence tomography (SD-OCT) images were analyzed using ImageJ2 to quantify ellipsoid zone damage.
Results: Five patients met the criteria for inclusion in this study. All patients were female, with a mean age of 69.5 ± 12.2 years. Patients had been taking HCQ for 18.2 years on average (range: 5-32 years). 40% of patients were overdosed according to real weight guidelines and 60% by ideal weight guidelines. All patients demonstrated worsening of retinopathy following drug discontinuation. The length of parafoveal zones of EZ hyporeflectivity on SD-OCT increased by an average of 26.8 ± 8.6% in right eyes and 22.5 ± 15.0% in left eyes over an average follow-up period of 31.4 months (range 8-71 months).
Conclusion: Progression of HCQ retinopathy can occur even when HCQ is discontinued before RPE damage. Ophthalmologists should be aware of the risks associated with HCQ use following damage to the…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- A Coupled SYSTEM of Intracellular Ca 2+ Clocks and Surface Membrane Voltage Clocks Controls the Timekeeping Mechanism of the Heart’s Pacemaker
- A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
- Cancer epigenetics: Moving forward
- Current developments in LC-MS for pharmaceutical analysis
- Myricetin: A comprehensive review on its biological potentials
- A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.